Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells
AIM: To explore the anti-hepatitis B virus (HBV) effects of Boehmeria nivea (B. nivea) root extract (BNE) by using the HepG2 2.2.15 cell model system. METHODS: Hepatitis B surface antigen (HBsAg), hepatitis B virus e antigen (HBeAg), and HBV DNA were measured by using ELISA and real-time PCR, respec...
Saved in:
Published in | World journal of gastroenterology : WJG Vol. 12; no. 35; pp. 5721 - 5725 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
Department of Life Sciences and Institute of Biotechnology, National Tsing Hua University, Hsinchu, Taiwan 30013, China%Department of Life Sciences and Institute of Biotechnology, National Tsing Hua University, Hsinchu, Taiwan 30013, China
21.09.2006
Department of Bioresources, Da-Yeh University, Changhua, Taiwan 515, China%Division of Research and Development, Development Center for Biotechnology, Xizhi City, Taipei County, Taiwan 221, China Baishideng Publishing Group Co., Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | AIM: To explore the anti-hepatitis B virus (HBV) effects of Boehmeria nivea (B. nivea) root extract (BNE) by using the HepG2 2.2.15 cell model system. METHODS: Hepatitis B surface antigen (HBsAg), hepatitis B virus e antigen (HBeAg), and HBV DNA were measured by using ELISA and real-time PCR, respectively. Viral DNA replication and RNA expression were determined by using Southern and Northern blot, respectively. RESULTS: In HepG2 2.2.15 cells, HBeAg (60%, P 〈 0.01) and particle-associated HBV DNA (〉 99%, P 〈 0.01) secretion into supernatant were significantly inhibited by BNE at a dose of 100 mg/L, whereas the HBsAg was not inhibited. With different doses of BNE, the reduced HBeAg was correlated with the inhibition of HBV DNA. The anti-HBV effect of BNE was not caused by its cytotoxicity to cells or inhibition of viral DNA replication and RNA expression. CONCLUSION: BNE could effectively reduce the HBV production and its anti-HBV machinery might differ from the nucleoside analogues. |
---|---|
Bibliography: | 14-1219/R Boehmeria nivea Medicinal herb Anti-hepatitis B virus Boehmeria nivea; Medicinal herb; Antiviral agent; Hepatitis B virus; Anti-hepatitis B virus; HepG2 2.2.15 Antiviral agent Hepatitis B virus HepG2 2.2.15 R512.62 Telephone: +886-2-26956933-5102 Fax: +886-2-66150063 Correspondence to: Dr. Jia-Ming Chang, Division of Research and Development, Development Center for Biotechnology, Xizhi City, Taipei County, Taiwan 221, China. jiaming@mail.dcb.org.tw Author contributions: All authors contributed equally to the work. |
ISSN: | 1007-9327 2219-2840 |
DOI: | 10.3748/wjg.v12.i35.5721 |